SPIA
ONCY

Steward Partners Investment Advisory’s Oncolytics Biotech ONCY Stock Holding History

Steward Partners Investment Advisory’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$550 – 4218
2025
Q1 		$550 Hold
1,000
– – ﹤0.01% 3851
2024
Q4 		$914 Buy
+1,000
New +$1.04K ﹤0.01% 3772
2022
Q2 		– Sell
-100
Closed – – 3330
2022
Q1 		$0 Hold
100
– – ﹤0.01% 3345
2021
Q4 		$0 Buy
+100
New +$185 ﹤0.01% 3278

Other funds holding ONCY

SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HL
HeadInvest LLC Portland, Maine $488M AUM 14.33% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.71B AUM 30.33% 1-Year Est. Return

Steward Partners Investment Advisory's ONCY Position: Q2 2025 in Review

Steward Partners Investment Advisory sold out of Oncolytics Biotech (ONCY) in Q2 2025, closing a stake of 1,000 shares — an estimated $550 sold.

Steward Partners Investment Advisory first reported a position in ONCY in Q4 2021 and held it in 4 quarters. The position peaked at $914 in Q4 2024. 55 funds tracked by Wall St. Rank hold ONCY as of Q2 2025.

  • Steward Partners Investment Advisory reported no remaining Oncolytics Biotech position as of Q2 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,000 Oncolytics Biotech shares in Q2 2025, an estimated $550.
  • Steward Partners Investment Advisory first reported a position in Oncolytics Biotech in Q4 2021 and held it in 4 quarters.
  • Steward Partners Investment Advisory's Oncolytics Biotech position peaked at $914 in Q4 2024.
  • 55 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2025, filed 12 Aug 2025.